A) U2OS cells transiently transfected with Flag-tagged RNF169 expression construct were subjected to IR treatment. Cells were subsequently processed for immunostaining experiments using anti-Flag (M2) and anti-53BP1 antibodies. Percentage of 53bp1 IRIFpositive cells from three independent experiments is shown. At least 100 cells were analysed; B) RNF169 and 53BP1 IRIF were assessed in HeLa cells following the same procedures described in (A) with the exception that cells were pre-extracted before immunostaining using anti-RNF169 and anti-53BP1 antibodies; C) U2OS cells stably expressing Flag-tagged RNF169 were processed as in (A) and were subjected to SR-SIM. Representative images showing the distribution of Flag (RNF169) and 53BP1 at IRIF are shown. Bars: 1 μm. A -C) DIvA-eRNF169 cells were induced with or without 1.0 μg/ml doxycycline for 24 hr. 4-OHT was added 4 hr before cells were processed for immunostaining experiments using indicated anitbodies. Data represents mean ± SEM from three independent experiments. At least 100 cells were analysed. ns, not signi cant; **p<0.01; ***p<0.001; D) DlvA-eRNF169∆MIU2 cells were processed and analysed as in (A-C); E) DlvA-eRNF169 cells were synchronised in G1 phase with Mimosine (24 hr) or not. S and G2 cell populations were collected 6 hr or 12 hr after release from G1phase (right panel). Cells were processed for immunostaining experiments as in (A-C) or for ow cytometric analysis by propidium iodide staining; F) Quanti cation for (E) is shown. Data represents mean ± SEM from three independent experiments. At least 100 cells were analysed. ***p<0.001. Figure S3 A -B) DIvA-eRNF169 cells were induced with indicated concentrations of doxycycline (Dox) for 24 hr followed by addition of 4-OHT for 4 hr. Immunofluorescence staining (A) and Western blotting analysis (B) were performed using indicated antibodies. Percentage of 53BP1 foci positive cells is shown. Data was derived from three independent experiments and at least 100 cells were counted; C -E) DIvA-eRNF169 cells were induced with or without 0.02 μg/ml doxycycline for 24 hr. 4-OHT was added 4 hr before cells were processed for immunostaining experimentations using indicated antibodies. Nuclei were stained with DAPI. Figure S4 A -B) Control or RAP80 KO (derived from RAP80-targeting gRNA1 or gRNA2) U2OS cells were processed for Western blotting experiments (A) or for immunostaining experiments (B) following IR treatment using indicated antibodies. Asterick denotes non-speci c bands; Nuclei were stained with DAPI. 
Chr1_6
Figure S7
AsiSI-ER-U2OS cells were treated with or without 4-OHT for 4 hr. Thereafter cells were processed for ChIPqPCR experimentations to assess chromatin distribution of CtIP, RPA-1 and RAD51 using indicated antibdodies. Data shows mean ± SEM (of 2 technical repeats) from one representative experiment (n = 2). 
Chr1_12
Flag (eRNF169) Flag (eRNF168) ChIP-qPCR reveals the distribution of Flag-tagged RNF169 and RNF168 at AsiSI-induced DSBs. AsiSI-ER-U2OS cells that stably express Flag-tagged RNF169 or RNF168 were treated with or without 4-OHT for 4 hr. Cells were subsequently processed for ChIP-qPCR experimentations. Each data point represents mean ± SEM (of 2 technical repeats) from one representative experiment (n = 2).
Figure S8 + 4-OHT Figure S9 kDa kDa E A) DlvA-eRNF169 cells pre-treated with indicated siRNAs were induced with 1.0 μg/ml doxycycline for 24 hr. Cells were subsequently incubated with 4-OHT for 4 hr before subjecting to ChIP-qPCR experimentations to determine Flag (eRNF169) enrichment at AsiSI-induced DSBs. Data represents mean ± SEM (of 2 technical repeats) from one representative experiment (n = 2); B) Western blotting experiment was performed to assess RNAi-mediated knockdown e ciency in cells used in (A); C) DlvA-eRNF169 infected with lentiviral particles containing gRNA vector control (Vector) or gRNAs that target MRE11, RAD50 or NBS1 were incubated with 4-OHT4 for 4 hr. Cells were processed for ChIP-qPCR experimentations as in (A). Data represents mean ± SEM (of 2 technical repeats) from one representative experiment (n = 2); D) Western blotting experiment was performed to assess protein expression in cells described in (C); E) Lysates derived from HEK293T cells transiently transfected with plasmids encoding Flag-tagged DYKR1A, MRE11, RAD50, NBS1 and RNF8 were incubated with puri ed MBP-RNF169 proteins conjugated on amylose beads. Bound complexes were processed for Western blotting experimentations using indicated antibodies. MBP-RNF169 proteins were visualised by coomassie stain. A) DR-U2OS (Control and 53BP1 KO) cells were transfected with indicated siRNAs. Cells were subsequently electroporated with an I-SceI expression construct, and were subjected to ow cytometic analysis to determine GFP positive cell percentage. Data represents mean ± SEM from three independent experiments. *p<0.05; **p<0.01; ns, not signi cant; B) Western blotting experiment was performed to assess RNAi-mediated knockdown e ciency in cells used in (A). Asterick denotes non-speci c bands. C) DR-U2OS-eRNF169 cells pre-treated with indicated siRNAs were electroporated with the I-SceI endonuclease expression construct. Thereafter cells were incubated with or without 2 μg/ml doxycycline (Dox) for 48 hr. Cells were subsequently harvested for flow cytometic analysis to determine percentage of GFP-positive cell population. Mock electroporation (-I-SceI) was used as a negative control. Data represents mean ± SEM from three independent experiments. ns, not significant; D) Western blotting experiment was performed to assess RNAi-mediated knockdown efficiency for cells used in (A). Figure S15 DlvA-eRNF169 A A) DIvA-eRNF169 cells were pre-treated with or without 1.0 μg/ml doxycycline for 24 hr to induce eRNF169 expression. 4-OHT was added 4 hr before cells were processed for immunostaining experiments using indicated antibodies. Nuclei were labaled with DAPI ; B) AsiSI-ER-U2OS cells (WT and RNF169 KO) were incubated with or without 4-OHT for 4 hr. Cells were subsequently processed for ChIP experimentations using indicated antibodies. Results (mean ± SEM of 2 technical repeats) from one representative experiment are shown, n = 2; C) ChIP-qPCR analysis of RAD51 and BRCA1 on RAD51-bound (DSBIV-DSBVI) DSBs in Control and RNF169 KO cells. Box and whisker plots represent fold change of RAD51 and BRCA1 occupancy before and after 4-OHT treatment at 80bp and 800bp from indicated AsiSI-induced DSBs. ns, not signi cant. Results shown are derived from one representative experiment (n = 2). 
GFP-RAD52
GFP-RAD52 Relative Fluorescence Intensity ** ** ** ** * * * ns ns ns Damaged A & B) RNF169 promotes accumulation of GFP-RAD52 at laser-induced DNA damage tracks. U2OS cells or its RNF169 KO derivatives transiently transfected with GFP-RAD52 expression construct were microirradiated using a two-photon laser (750 nm). Cell images were taken before and after microirradiation at 2-min intervals. Representative images from each group are shown (A); B) Quanti cation for (A) is shown. Intensities of GFP-RAD52 at laser-induced DNA damage tracks were analysed using Image J software. At least 5 cells were analysed for each group. ns, not signi cant; *p<0.05; **p<0.01. In response to DSBs, RNF169 and 53BP1 are recruited to DSB-anking chromatin. RNF169 is deposited at DSB end-proximal regions whereas 53BP1 enriches at distal regions surrounding DSBs. Dynamic equilibrium of RNF169 and 53BP1 at DSB chromatin supports appropriate DDRs and promotes DSB repair via high-delity HR (middle panel). RNF169 de ciency results in impaired DSB end resection and repair defects in resectiondependent repair pathways, namely, aNHEJ, HR and SSA (left panel). On the other hand, over-expression of RNF169 skews repair of DSBs to the mutagenic SSA repair pathway, in part, by counteracting 53BP1 activities at DSBs (right panel). 
